Publications by authors named "Peter H Watson"

100Publications

Improving Academic Biobank Value and Sustainability Through an Outputs Focus.

Value Health 2020 08 2;23(8):1072-1078. Epub 2020 Aug 2.

NSW Health Statewide Biobank, NSW Health Pathology, Professor Marie Bashir Centre, Camperdown, NSW, Australia. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jval.2020.05.010DOI Listing
August 2020

UBCx "Biospecimen Research Methods Course".

Biopreserv Biobank 2020 Feb;18(1):4-6

Biobanking and Biospecimen Research Services, Trev and Joyce Deeley Research Centre, BC Cancer, Victoria, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1089/bio.2019.0046DOI Listing
February 2020

Comparison and Analysis of Two Internationally Recognized Biobanking Standards.

Biopreserv Biobank 2020 Apr 27;18(2):82-89. Epub 2020 Jan 27.

Office of Biobank Education and Research, Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, British Columbia, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1089/bio.2019.0126DOI Listing
April 2020

Biobanking Education.

Biopreserv Biobank 2020 Feb 22;18(1):1-3. Epub 2020 Jan 22.

Department of Pathology and Laboratory Medicine, Office of Biobank Education and Research, University of British Columbia, British Columbia, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1089/bio.2019.29062.mjcDOI Listing
February 2020

Precision medicine: Driving the evolution of biobanking quality.

Healthc Manage Forum 2020 May 20;33(3):102-106. Epub 2020 Jan 20.

Canadian Tissue Repository Network, Vancouver, British Columbia, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/0840470419898874DOI Listing
May 2020

Access ISBER Best Practice Education Online and Keep Your Practices Current.

Biopreserv Biobank 2019 Dec 19;17(6):625-626. Epub 2019 Nov 19.

Biobanking and Biospecimen Research Services, Deeley Research Centre, British Columbia Cancer-Victoria Center, Victoria, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1089/bio.2019.29061.ljmDOI Listing
December 2019

Canadian Tissue Repository Network Biobank Certification Program: Update and Review of the Program from 2011 to 2018.

Biopreserv Biobank 2019 Dec 13;17(6):530-538. Epub 2019 Jun 13.

Biobanking and Biospecimen Research Services, Deeley Research Centre, British Columbia Cancer-Victoria Center, Victoria, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1089/bio.2019.0015DOI Listing
December 2019

Biospecimen Complexity and the Evolution of Biobanks.

Biopreserv Biobank 2019 Jun;17(3):264-270

1 Biobanking and Biospecimen Research Services, Deeley Research Centre, British Columbia Cancer-Victoria Center and University of British Columbia, Victoria, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1089/bio.2018.0120DOI Listing
June 2019

Biobank: What's in a Name?

Biopreserv Biobank 2019 Jun;17(3):204-208

5 Division of Anatomic Pathology, Department of Pathology, The University of Alabama at Birmingham (UAB), Birmingham, Alabama.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1089/bio.2019.29053.mjbDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7065495PMC
June 2019

The Importance of Human Tissue Bioresources in Advancing Biomedical Research.

Biopreserv Biobank 2019 Jun;17(3):209-212

1 Department of Pathology, The University of Alabama at Birmingham, Birmingham, Alabama.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1089/bio.2019.0039DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7061295PMC
June 2019

Biospecimen Data Reporting in the Research Literature.

Biopreserv Biobank 2019 Aug 30;17(4):326-333. Epub 2019 Apr 30.

1Office of Biobank Education and Research, Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1089/bio.2018.0143DOI Listing
August 2019

Research Perspective on Utilizing and Valuing Tumor Biobanks.

Biopreserv Biobank 2019 Jun 21;17(3):219-229. Epub 2018 Dec 21.

2 Office of Biobank Education and Research, Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1089/bio.2018.0099DOI Listing
June 2019

Malignant Epithelial Transformation in Phyllodes Tumor: A Population-Based Case Series.

Cureus 2017 Nov 3;9(11):e1815. Epub 2017 Nov 3.

Radiation Oncology, University of British Columbia, BC Cancer Agency.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.7759/cureus.1815DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5752221PMC
November 2017

An Australian Biobank Certification Scheme: A Study of Economic Costs to Participating Biobanks.

Biopreserv Biobank 2018 Feb 7;16(1):53-58. Epub 2017 Dec 7.

1 Health Research Economics, Hunter Medical Research Institute , New Lambton, Heights, NSW, Australia .

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1089/bio.2017.0095DOI Listing
February 2018

PD-L1 and intratumoral immune response in breast cancer.

Oncotarget 2017 Aug 30;8(31):51641-51651. Epub 2017 May 30.

Trev & Joyce Deeley Research Centre, British Columbia Cancer Agency, Victoria, British Columbia, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.18632/oncotarget.18305DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5584276PMC
August 2017

Assessing Tumor-Infiltrating Lymphocytes in Solid Tumors: A Practical Review for Pathologists and Proposal for a Standardized Method from the International Immuno-Oncology Biomarkers Working Group: Part 2: TILs in Melanoma, Gastrointestinal Tract Carcinomas, Non-Small Cell Lung Carcinoma and Mesothelioma, Endometrial and Ovarian Carcinomas, Squamous Cell Carcinoma of the Head and Neck, Genitourinary Carcinomas, and Primary Brain Tumors.

Authors:
Shona Hendry Roberto Salgado Thomas Gevaert Prudence A Russell Tom John Bibhusal Thapa Michael Christie Koen van de Vijver M V Estrada Paula I Gonzalez-Ericsson Melinda Sanders Benjamin Solomon Cinzia Solinas Gert G G M Van den Eynden Yves Allory Matthias Preusser Johannes Hainfellner Giancarlo Pruneri Andrea Vingiani Sandra Demaria Fraser Symmans Paolo Nuciforo Laura Comerma E A Thompson Sunil Lakhani Seong-Rim Kim Stuart Schnitt Cecile Colpaert Christos Sotiriou Stefan J Scherer Michail Ignatiadis Sunil Badve Robert H Pierce Giuseppe Viale Nicolas Sirtaine Frederique Penault-Llorca Tomohagu Sugie Susan Fineberg Soonmyung Paik Ashok Srinivasan Andrea Richardson Yihong Wang Ewa Chmielik Jane Brock Douglas B Johnson Justin Balko Stephan Wienert Veerle Bossuyt Stefan Michiels Nils Ternes Nicole Burchardi Stephen J Luen Peter Savas Frederick Klauschen Peter H Watson Brad H Nelson Carmen Criscitiello Sandra O'Toole Denis Larsimont Roland de Wind Giuseppe Curigliano Fabrice André Magali Lacroix-Triki Mark van de Vijver Federico Rojo Giuseppe Floris Shahinaz Bedri Joseph Sparano David Rimm Torsten Nielsen Zuzana Kos Stephen Hewitt Baljit Singh Gelareh Farshid Sibylle Loibl Kimberly H Allison Nadine Tung Sylvia Adams Karen Willard-Gallo Hugo M Horlings Leena Gandhi Andre Moreira Fred Hirsch Maria V Dieci Maria Urbanowicz Iva Brcic Konstanty Korski Fabien Gaire Hartmut Koeppen Amy Lo Jennifer Giltnane Marlon C Rebelatto Keith E Steele Jiping Zha Kenneth Emancipator Jonathan W Juco Carsten Denkert Jorge Reis-Filho Sherene Loi Stephen B Fox

Adv Anat Pathol 2017 Nov;24(6):311-335

Departments of *Pathology §§§Medical Oncology, Peter MacCallum Cancer Centre, Melbourne †The Sir Peter MacCallum Department of Oncology Departments of **Pathology ∥∥Medicine, University of Melbourne ¶¶Department of Anatomical Pathology, Royal Melbourne Hospital, Parkville #Department of Anatomical Pathology, St Vincent's Hospital Melbourne, Fitzroy ††Department of Medical Oncology, Austin Health ‡‡Olivia Newton-John Cancer Research Institute, Heidelberg §§School of Cancer Medicine, La Trobe University, Bundoora §§§§§Centre for Clinical Research and School of Medicine, The University of Queensland ∥∥∥∥∥Pathology Queensland, Royal Brisbane and Women's Hospital, Brisbane §§§§§§§§§§The Cancer Research Program, Garvan Institute of Medical Research, Darlinghurst ∥∥∥∥∥∥∥∥∥∥Australian Clinical Labs, Bella Vista ‡‡‡‡‡‡‡‡‡‡‡‡Directorate of Surgical Pathology, SA Pathology §§§§§§§§§§§§Discipline of Medicine, Adelaide University, Adelaide, Australia ***********Department of Surgical Oncology, Netherlands Cancer Institute †††††††††††††Department of Pathology ##Divisions of Diagnostic Oncology & Molecular Pathology, Netherlands Cancer Institute-Antoni van Leeuwenhoek, Amsterdam, The Netherlands ###Université Paris-Est ****INSERM, UMR 955 ††††Département de pathologie, APHP, Hôpital Henri-Mondor, Créteil ∥∥∥∥∥∥∥∥∥Service de Biostatistique et d'Epidémiologie, Gustave Roussy, CESP, Inserm U1018, Université-Paris Sud, Université Paris-Saclay ¶¶¶¶¶¶¶¶¶¶INSERM Unit U981, and Department of Medical Oncology, Gustave Roussy, Villejuif ##########Faculté de Médecine, Université Paris Sud, Kremlin-Bicêtre †††††††Department of Surgical Pathology and Biopathology, Jean Perrin Comprehensive Cancer Centre ‡‡‡‡‡‡‡University of Auvergne UMR1240, Clermont-Ferrand, France ‡‡‡‡Department of Medicine, Clinical Division of Oncology §§§§Institute of Neurology, Comprehensive Cancer Centre Vienna, Medical University of Vienna, Vienna ††††††††††††††Institute of Pathology, Medical University of Graz, Austria ∥∥∥∥European Institute of Oncology ¶¶¶¶School of Medicine ######Department of Pathology, Istituto Europeo di Oncologia, University of Milan, Milan ¶¶¶¶¶¶¶¶¶¶¶¶¶Department of Surgery, Oncology and Gastroenterology, University of Padova #############Medical Oncology 2, Veneto Institute of Oncology IOV-IRCCS, Padua, Italy †††††Molecular Oncology Group, Vall d'Hebron Institute of Oncology, Barcelona †††††††††††Pathology Department, IIS-Fundacion Jimenez Diaz, UAM, Madrid, Spain §Department of Pathology and TCRU, GZA ¶¶¶Department of Pathology, GZA Ziekenhuizen, Antwerp ∥Laboratory of Experimental Urology, Department of Development and Regeneration, KU Leuven ‡‡‡‡‡‡‡‡‡‡‡Department of Pathology, University Hospital Leuven, Leuven, Belgium ¶Department of Pathology, AZ Klina, Brasschaat ††††††Department of Pathology, GZA Ziekenhuizen, Sint-Augustinus, Wilrijk ∥∥∥Molecular Immunology Unit ‡‡‡‡‡‡Department of Medical Oncology, Institut Jules Bordet, Université Libre de Bruxelles ‡Breast Cancer Translational Research Laboratory/Breast International Group, Institut Jules Bordet **************European Organisation for Research and Treatment of Cancer (EORTC) Headquarters *******Department of Pathology, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium §§§§§§§Department of Surgery, Kansai Medical School, Hirakata, Japan #######Severance Biomedical Science Institute and Department of Medical Oncology, Yonsei University College of Medicine, Seoul, South Korea ∥∥∥∥∥∥∥∥Tumor Pathology Department, Maria Sklodowska-Curie Memorial Cancer Center ¶¶¶¶¶¶¶¶Institute of Oncology, Gliwice Branch, Gliwice, Poland ‡‡‡‡‡‡‡‡‡‡‡‡‡‡Pathology and Tissue Analytics, Roche Innovation Centre Munich, Penzberg †††††††††Institute of Pathology, Charité Universitätsmedizin Berlin ‡‡‡‡‡‡‡‡‡VMscope GmbH, Berlin ¶¶¶¶¶¶¶¶¶German Breast Group GmbH, Neu-Isenburg, Germany **********Trev & Joyce Deeley Research Centre, British Columbia Cancer Agency ††††††††††Department of Biochemistry and Microbiology, University of Victoria, Victoria Departments of ‡‡‡‡‡‡‡‡‡‡Medical Genetics #########Pathology and Laboratory Medicine ¶¶¶¶¶¶¶¶¶¶¶Department of Pathology and Laboratory Medicine, Genetic Pathology Evaluation Centre, University of British Columbia, Vancouver, BC ###########Department of Pathology and Laboratory Medicine, University of Ottawa, Ottawa, Canada §§§§§§§§§§§Department of Pathology and Laboratory Medicine, Weill Cornell Medical College, Doha, Qatar ‡‡‡‡‡‡‡‡Department of Pathology and Laboratory Medicine, Rhode Island Hospital and Lifespan Medical Center §§§§§§§§Warren Alpert Medical School of Brown University, Providence ¶¶¶¶¶National Surgical Adjuvant Breast and Bowel Project Operations Center/NRG Oncology, Pittsburgh, PA †††Breast Cancer Research Program, Vanderbilt Ingram Cancer Center, Vanderbilt University Departments of ‡‡‡Pathology, Microbiology and Immunology ########Department of Medicine, Vanderbilt University Medical Centre *********Vanderbilt Ingram Cancer Center, Nashville §§§§§§§§§Department of Pathology, Yale University School of Medicine, New Haven ∥∥∥∥∥∥∥∥∥∥∥Department of Oncology, Montefiore Medical Centre, Albert Einstein College of Medicine ∥∥∥∥∥∥∥Montefiore Medical Center ¶¶¶¶¶¶¶The Albert Einstein College of Medicine, Bronx, NY ********Department of Pathology, Brigham and Women's Hospital #####Cancer Research Institute and Department of Pathology, Beth Israel Deaconess Cancer Center ******Harvard Medical School ¶¶¶¶¶¶¶¶¶¶¶¶Division of Hematology-Oncology, Beth Israel Deaconess Medical Center ††††††††Department of Cancer Biology ‡‡‡‡‡‡‡‡‡‡‡‡‡Dana-Farber Cancer Institute, Boston, MA ∥∥∥∥∥∥∥∥∥∥∥∥∥Department of Medicine, Division of Medical Oncology, University of Colorado Anschutz Medical Campus, Aurora, CO ‡‡‡‡‡Department of Cancer Biology, Mayo Clinic, Jacksonville, FL ∥∥∥∥∥∥Department of Pathology and Laboratory Medicine, Indiana University, Indianapolis, IN ¶¶¶¶¶¶Cancer Immunotherapy Trials Network, Central Laboratory and Program in Immunology, Fred Hutchinson Cancer Research Center, Seattle, WA ††††††††††††Department of Pathology, New York University Langone Medical Centre ############New York University Medical School *************Perlmutter Cancer Center §§§§§§§§§§§§§Pulmonary Pathology, New York University Center for Biospecimen Research and Development, New York University ***************Department of Pathology, Memorial Sloan-Kettering Cancer Center ####Departments of Radiation Oncology and Pathology, Weill Cornell Medicine, New York, NY *****Department of Pathology, University of Texas M.D. Anderson Cancer Center, Houston, TX ∥∥∥∥∥∥∥∥∥∥∥∥Pathology Department, Stanford University Medical Centre, Stanford ∥∥∥∥∥∥∥∥∥∥∥∥∥∥Department of Pathology, Stanford University, Palo Alto ***Department of Pathology, School of Medicine, University of California, San Diego §§§§§§§§§§§§§§Research Pathology, Genentech Inc., South San Francisco, CA *************Laboratory of Pathology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda ¶¶¶¶¶¶¶¶¶¶¶¶¶¶Translational Sciences, MedImmune, Gaithersberg, MD §§§§§§Academic Medical Innovation, Novartis Pharmaceuticals Corporation, East Hanover ##############Translational Medicine, Merck & Co. Inc., Kenilworth, NJ.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/PAP.0000000000000161DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5638696PMC
November 2017

Assessing Tumor-infiltrating Lymphocytes in Solid Tumors: A Practical Review for Pathologists and Proposal for a Standardized Method From the International Immunooncology Biomarkers Working Group: Part 1: Assessing the Host Immune Response, TILs in Invasive Breast Carcinoma and Ductal Carcinoma In Situ, Metastatic Tumor Deposits and Areas for Further Research.

Authors:
Shona Hendry Roberto Salgado Thomas Gevaert Prudence A Russell Tom John Bibhusal Thapa Michael Christie Koen van de Vijver M V Estrada Paula I Gonzalez-Ericsson Melinda Sanders Benjamin Solomon Cinzia Solinas Gert G G M Van den Eynden Yves Allory Matthias Preusser Johannes Hainfellner Giancarlo Pruneri Andrea Vingiani Sandra Demaria Fraser Symmans Paolo Nuciforo Laura Comerma E A Thompson Sunil Lakhani Seong-Rim Kim Stuart Schnitt Cecile Colpaert Christos Sotiriou Stefan J Scherer Michail Ignatiadis Sunil Badve Robert H Pierce Giuseppe Viale Nicolas Sirtaine Frederique Penault-Llorca Tomohagu Sugie Susan Fineberg Soonmyung Paik Ashok Srinivasan Andrea Richardson Yihong Wang Ewa Chmielik Jane Brock Douglas B Johnson Justin Balko Stephan Wienert Veerle Bossuyt Stefan Michiels Nils Ternes Nicole Burchardi Stephen J Luen Peter Savas Frederick Klauschen Peter H Watson Brad H Nelson Carmen Criscitiello Sandra O'Toole Denis Larsimont Roland de Wind Giuseppe Curigliano Fabrice André Magali Lacroix-Triki Mark van de Vijver Federico Rojo Giuseppe Floris Shahinaz Bedri Joseph Sparano David Rimm Torsten Nielsen Zuzana Kos Stephen Hewitt Baljit Singh Gelareh Farshid Sibylle Loibl Kimberly H Allison Nadine Tung Sylvia Adams Karen Willard-Gallo Hugo M Horlings Leena Gandhi Andre Moreira Fred Hirsch Maria V Dieci Maria Urbanowicz Iva Brcic Konstanty Korski Fabien Gaire Hartmut Koeppen Amy Lo Jennifer Giltnane Marlon C Rebelatto Keith E Steele Jiping Zha Kenneth Emancipator Jonathan W Juco Carsten Denkert Jorge Reis-Filho Sherene Loi Stephen B Fox

Adv Anat Pathol 2017 Sep;24(5):235-251

Departments of *Pathology §§§Medical Oncology, Peter MacCallum Cancer Centre, Melbourne †The Sir Peter MacCallum Department of Oncology Departments of **Pathology ∥∥Medicine, University of Melbourne ¶¶Department of Anatomical Pathology, Royal Melbourne Hospital, Parkville #Department of Anatomical Pathology, St Vincent's Hospital Melbourne, Fitzroy ††Department of Medical Oncology, Austin Health ‡‡Olivia Newton-John Cancer Research Institute, Heidelberg §§School of Cancer Medicine, La Trobe University, Bundoora §§§§§Centre for Clinical Research and School of Medicine, The University of Queensland ∥∥∥∥∥Pathology Queensland, Royal Brisbane and Women's Hospital, Brisbane §§§§§§§§§§The Cancer Research Program, Garvan Institute of Medical Research, Darlinghurst ∥∥∥∥∥∥∥∥∥∥Australian Clinical Labs, Bella Vista ‡‡‡‡‡‡‡‡‡‡‡‡Directorate of Surgical Pathology, SA Pathology §§§§§§§§§§§§Discipline of Medicine, Adelaide University, Adelaide, Australia ***********Department of Surgical Oncology, Netherlands Cancer Institute †††††††††††††Department of Pathology ##Divisions of Diagnostic Oncology & Molecular Pathology, Netherlands Cancer Institute-Antoni van Leeuwenhoek, Amsterdam, The Netherlands ###Université Paris-Est ****INSERM, UMR 955 ††††Département de pathologie, APHP, Hôpital Henri-Mondor, Créteil ∥∥∥∥∥∥∥∥∥Service de Biostatistique et d'Epidémiologie, Gustave Roussy, CESP, Inserm U1018, Université-Paris Sud, Université Paris-Saclay ¶¶¶¶¶¶¶¶¶¶INSERM Unit U981, and Department of Medical Oncology, Gustave Roussy, Villejuif ##########Faculté de Médecine, Université Paris Sud, Kremlin-Bicêtre †††††††Department of Surgical Pathology and Biopathology, Jean Perrin Comprehensive Cancer Centre ‡‡‡‡‡‡‡University of Auvergne UMR1240, Clermont-Ferrand, France ‡‡‡‡Department of Medicine, Clinical Division of Oncology §§§§Institute of Neurology, Comprehensive Cancer Centre Vienna, Medical University of Vienna, Vienna ††††††††††††††Institute of Pathology, Medical University of Graz, Austria ∥∥∥∥European Institute of Oncology ¶¶¶¶School of Medicine ######Department of Pathology, Istituto Europeo di Oncologia, University of Milan, Milan ¶¶¶¶¶¶¶¶¶¶¶¶¶Department of Surgery, Oncology and Gastroenterology, University of Padova #############Medical Oncology 2, Veneto Institute of Oncology IOV-IRCCS, Padua, Italy †††††Molecular Oncology Group, Vall d'Hebron Institute of Oncology, Barcelona †††††††††††Pathology Department, IIS-Fundacion Jimenez Diaz, UAM, Madrid, Spain §Department of Pathology and TCRU, GZA ¶¶¶Department of Pathology, GZA Ziekenhuizen, Antwerp ∥Laboratory of Experimental Urology, Department of Development and Regeneration, KU Leuven ‡‡‡‡‡‡‡‡‡‡‡Department of Pathology, University Hospital Leuven, Leuven, Belgium ¶Department of Pathology, AZ Klina, Brasschaat ††††††Department of Pathology, GZA Ziekenhuizen, Sint-Augustinus, Wilrijk ∥∥∥Molecular Immunology Unit ‡‡‡‡‡‡Department of Medical Oncology, Institut Jules Bordet, Université Libre de Bruxelles ‡Breast Cancer Translational Research Laboratory/Breast International Group, Institut Jules Bordet **************European Organisation for Research and Treatment of Cancer (EORTC) Headquarters *******Department of Pathology, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium §§§§§§§Department of Surgery, Kansai Medical School, Hirakata, Japan #######Severance Biomedical Science Institute and Department of Medical Oncology, Yonsei University College of Medicine, Seoul, South Korea ∥∥∥∥∥∥∥∥Tumor Pathology Department, Maria Sklodowska-Curie Memorial Cancer Center ¶¶¶¶¶¶¶¶Institute of Oncology, Gliwice Branch, Gliwice, Poland ‡‡‡‡‡‡‡‡‡‡‡‡‡‡Pathology and Tissue Analytics, Roche Innovation Centre Munich, Penzberg †††††††††Institute of Pathology, Charité Universitätsmedizin Berlin ‡‡‡‡‡‡‡‡‡VMscope GmbH, Berlin ¶¶¶¶¶¶¶¶¶German Breast Group GmbH, Neu-Isenburg, Germany **********Trev & Joyce Deeley Research Centre, British Columbia Cancer Agency ††††††††††Department of Biochemistry and Microbiology, University of Victoria, Victoria Departments of ‡‡‡‡‡‡‡‡‡‡Medical Genetics #########Pathology and Laboratory Medicine ¶¶¶¶¶¶¶¶¶¶¶Department of Pathology and Laboratory Medicine, Genetic Pathology Evaluation Centre, University of British Columbia, Vancouver, BC ###########Department of Pathology and Laboratory Medicine, University of Ottawa, Ottawa, Canada §§§§§§§§§§§Department of Pathology and Laboratory Medicine, Weill Cornell Medical College, Doha, Qatar ‡‡‡‡‡‡‡‡Department of Pathology and Laboratory Medicine, Rhode Island Hospital and Lifespan Medical Center §§§§§§§§Warren Alpert Medical School of Brown University, Providence ¶¶¶¶¶National Surgical Adjuvant Breast and Bowel Project Operations Center/NRG Oncology, Pittsburgh, PA †††Breast Cancer Research Program, Vanderbilt Ingram Cancer Center, Vanderbilt University Departments of ‡‡‡Pathology, Microbiology and Immunology ########Department of Medicine, Vanderbilt University Medical Centre *********Vanderbilt Ingram Cancer Center, Nashville §§§§§§§§§Department of Pathology, Yale University School of Medicine, New Haven ∥∥∥∥∥∥∥∥∥∥∥Department of Oncology, Montefiore Medical Centre, Albert Einstein College of Medicine ∥∥∥∥∥∥∥Montefiore Medical Center ¶¶¶¶¶¶¶The Albert Einstein College of Medicine, Bronx, NY ********Department of Pathology, Brigham and Women's Hospital #####Cancer Research Institute and Department of Pathology, Beth Israel Deaconess Cancer Center ******Harvard Medical School ¶¶¶¶¶¶¶¶¶¶¶¶Division of Hematology-Oncology, Beth Israel Deaconess Medical Center ††††††††Department of Cancer Biology ‡‡‡‡‡‡‡‡‡‡‡‡‡Dana-Farber Cancer Institute, Boston, MA ∥∥∥∥∥∥∥∥∥∥∥∥∥Department of Medicine, Division of Medical Oncology, University of Colorado Anschutz Medical Campus, Aurora, CO ‡‡‡‡‡Department of Cancer Biology, Mayo Clinic, Jacksonville, FL ∥∥∥∥∥∥Department of Pathology and Laboratory Medicine, Indiana University, Indianapolis, IN ¶¶¶¶¶¶Cancer Immunotherapy Trials Network, Central Laboratory and Program in Immunology, Fred Hutchinson Cancer Research Center, Seattle, WA ††††††††††††Department of Pathology, New York University Langone Medical Centre ############New York University Medical School *************Perlmutter Cancer Center §§§§§§§§§§§§§Pulmonary Pathology, New York University Center for Biospecimen Research and Development, New York University ***************Department of Pathology, Memorial Sloan-Kettering Cancer Center ####Departments of Radiation Oncology and Pathology, Weill Cornell Medicine, New York, NY *****Department of Pathology, University of Texas M.D. Anderson Cancer Center, Houston, TX ∥∥∥∥∥∥∥∥∥∥∥∥Pathology Department, Stanford University Medical Centre, Stanford ∥∥∥∥∥∥∥∥∥∥∥∥∥∥Department of Pathology, Stanford University, Palo Alto ***Department of Pathology, School of Medicine, University of California, San Diego §§§§§§§§§§§§§§Research Pathology, Genentech Inc., South San Francisco, CA *************Laboratory of Pathology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda ¶¶¶¶¶¶¶¶¶¶¶¶¶¶Translational Sciences, MedImmune, Gaithersberg, MD §§§§§§Academic Medical Innovation, Novartis Pharmaceuticals Corporation, East Hanover ##############Translational Medicine, Merck & Co. Inc., Kenilworth, NJ.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/PAP.0000000000000162DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5564448PMC
September 2017

The Canadian Tissue Repository Network Biobank Certification and the College of American Pathologists Biorepository Accreditation Programs: Two Strategies for Knowledge Dissemination in Biobanking.

Biopreserv Biobank 2017 Feb 14;15(1):9-16. Epub 2016 Oct 14.

1 Canadian Tissue Repository Network , Vancouver, British Columbia, Canada .

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1089/bio.2016.0021DOI Listing
February 2017

Biospecimen User Fees: Global Feedback on a Calculator Tool.

Biopreserv Biobank 2017 Feb 30;15(1):57-64. Epub 2016 Aug 30.

1 Department of Pathology and Laboratory Medicine, Office of Biobank Education and Research (OBER), University of British Columbia , Vancouver, Canada .

View Article

Download full-text PDF

Source
http://www.liebertpub.com/doi/10.1089/bio.2016.0027
Publisher Site
http://dx.doi.org/10.1089/bio.2016.0027DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5335806PMC
February 2017

Biospecimen Complexity-the Next Challenge for Cancer Research Biobanks?

Authors:
Peter H Watson

Clin Cancer Res 2017 Feb 22;23(4):894-898. Epub 2016 Aug 22.

Trev and Joyce Deeley Research Centre, British Columbia Cancer Agency, Victoria, British Columbia, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-16-1406DOI Listing
February 2017

CD103 and Intratumoral Immune Response in Breast Cancer.

Clin Cancer Res 2016 Dec 7;22(24):6290-6297. Epub 2016 Jun 7.

Trev & Joyce Deeley Research Centre, British Columbia Cancer Agency, Victoria, British Columbia, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-16-0732DOI Listing
December 2016

CD74 and intratumoral immune response in breast cancer.

Oncotarget 2017 Feb;8(8):12664-12674

Trev and Joyce Deeley Research Centre, British Columbia Cancer Agency, Victoria, British Columbia, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.18632/oncotarget.8610DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5355043PMC
February 2017

A Model to Estimate Frozen Tissue Collection Targets in Biobanks to Support Cancer Research.

Biopreserv Biobank 2015 Oct 29;13(5):356-62. Epub 2015 Sep 29.

1 Office of Biobank Education and Research , Department of Pathology and Laboratory Medicine, BC Cancer Agency and UBC, Vancouver, British Columbia, Canada .

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1089/bio.2014.0081DOI Listing
October 2015

The importance of biobanking in cancer research.

Biopreserv Biobank 2015 Jun;13(3):172-7

1Tumour Tissue Repository, Trev and Joyce Deeley Research Centre, BC Cancer Agency, Victoria, British Columbia, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1089/bio.2014.0061DOI Listing
June 2015

Intratumoural inflammation and endocrine resistance in breast cancer.

Endocr Relat Cancer 2015 Feb 17;22(1):R51-67. Epub 2014 Nov 17.

Deeley Research CentreBritish Columbia Cancer Agency, 2410 Lee Avenue, Victoria, British Columbia, Canada V8R 6V5Translational Gastroenterology UnitNuffield Department of Medicine, John Radcliffe Hospital, University of Oxford, Oxford, UKDepartment of Biochemistry and Medical Genetics and the Manitoba Institute of Cell BiologyUniversity of Manitoba and CancerCare Manitoba, 675 McDermot Avenue, Winnipeg, Manitoba, CanadaDepartment of Biochemistry and MicrobiologyUniversity of Victoria, Victoria, British Columbia, CanadaDepartment of Pathology and Laboratory MedicineUniversity of British Columbia, Vancouver, British Columbia, Canada Deeley Research CentreBritish Columbia Cancer Agency, 2410 Lee Avenue, Victoria, British Columbia, Canada V8R 6V5Translational Gastroenterology UnitNuffield Department of Medicine, John Radcliffe Hospital, University of Oxford, Oxford, UKDepartment of Biochemistry and Medical Genetics and the Manitoba Institute of Cell BiologyUniversity of Manitoba and CancerCare Manitoba, 675 McDermot Avenue, Winnipeg, Manitoba, CanadaDepartment of Biochemistry and MicrobiologyUniversity of Victoria, Victoria, British Columbia, CanadaDepartment of Pathology and Laboratory MedicineUniversity of British Columbia, Vancouver, British Columbia, Canada Deeley Research CentreBritish Columbia Cancer Agency, 2410 Lee Avenue, Victoria, British Columbia, Canada V8R 6V5Translational Gastroenterology UnitNuffield Department of Medicine, John Radcliffe Hospital, University of Oxford, Oxford, UKDepartment of Biochemistry and Medical Genetics and the Manitoba Institute of Cell BiologyUniversity of Manitoba and CancerCare Manitoba, 675 McDermot Avenue, Winnipeg, Manitoba, CanadaDepartment of Biochemistry and MicrobiologyUniversity of Victoria, Victoria, British Columbia, CanadaDepartment of Pathology and Laboratory MedicineUniversity of British Columbia, Vancouver, British Columbia, Canada

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1530/ERC-14-0096DOI Listing
February 2015

Funding sources for Canadian biorepositories: the role of user fees and strategies to help fill the gap.

Biopreserv Biobank 2014 Oct 14;12(5):300-5. Epub 2014 Oct 14.

1 Canadian Tumour Repository Network , Victoria, Winnipeg, Manitoba, Canada .

View Article

Download full-text PDF

Source
http://www.liebertpub.com/doi/10.1089/bio.2014.0052
Publisher Site
http://dx.doi.org/10.1089/bio.2014.0052DOI Listing
October 2014

A practical tool for modeling biospecimen user fees.

Biopreserv Biobank 2014 Aug;12(4):234-9

1 University of British Columbia Office of Biobank Education and Research , Vancouver, British Columbia, Canada .

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1089/bio.2014.0008DOI Listing
August 2014

Biobank classification: communicating biorepository diversity.

Authors:
Peter H Watson

Biopreserv Biobank 2014 Jun;12(3):163-4

BC Cancer Agency , Victoria, British Columbia Canada .

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1089/bio.2014.1231DOI Listing
June 2014

Individual investigator profiles of biospecimen use in cancer research.

Biopreserv Biobank 2014 Jun 11;12(3):192-8. Epub 2014 Jun 11.

1 Tumour Tissue Repository, Trev and Joyce Deeley Research Centre, BC Cancer Agency , Victoria, British Columbia, Canada .

View Article

Download full-text PDF

Source
http://www.liebertpub.com/doi/10.1089/bio.2013.0092
Publisher Site
http://dx.doi.org/10.1089/bio.2013.0092DOI Listing
June 2014

Impact of a Permission to Contact (PTC) platform on biobank enrollment and efficiency.

Biopreserv Biobank 2013 Jun 31;11(3):144-8. Epub 2013 May 31.

1 Tumour Tissue Repository, British Columbia (BC) Cancer Agency , Victoria, British Columbia, Canada .

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1089/bio.2013.0004DOI Listing
June 2013

Permission to contact (PTC)--a strategy to enhance patient engagement in translational research.

Biopreserv Biobank 2013 Aug;11(4):245-52

1 University of British Columbia, Office of Biobank Education and Research , Vancouver, British Columbia, Canada .

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1089/bio.2013.0023DOI Listing
August 2013

Markers of T cell infiltration and function associate with favorable outcome in vascularized high-grade serous ovarian carcinoma.

PLoS One 2013 23;8(12):e82406. Epub 2013 Dec 23.

Trev and Joyce Deeley Research Centre, British Columbia Cancer Agency, Victoria, British Columbia, Canada ; Department of Biochemistry and Microbiology, University of Victoria, Victoria, British Columbia, Canada ; Department of Biology, University of Victoria, Victoria, British Columbia, Canada.

View Article

Download full-text PDF

Source
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0082406PLOS
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3871161PMC
March 2015

Surveillance of the tumor mutanome by T cells during progression from primary to recurrent ovarian cancer.

Clin Cancer Res 2014 Mar 9;20(5):1125-34. Epub 2013 Dec 9.

Authors' Affiliations: Trev and Joyce Deeley Research Centre, British Columbia Cancer Agency; Department of Biochemistry and Microbiology, University of Victoria, Victoria; Michael Smith Genome Sciences Centre, British Columbia Cancer Agency, Vancouver; Departments of Medical Genetics and Pathology and Laboratory Medicine, University of British Columbia, Vancouver; and Department of Molecular Biology and Biochemistry, Simon Fraser University, Burnaby, British Columbia, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-13-2147DOI Listing
March 2014

Biospecimen use correlates with emerging techniques in cancer research: impact on planning future biobanks.

Biopreserv Biobank 2012 Dec;10(6):518-25

1 Tumour Tissue Repository and Deeley Research Centre, Vancouver Island Centre, BC Cancer Agency , British Columbia, Canada .

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1089/bio.2012.0038DOI Listing
December 2012

An online tool for improving biospecimen data element reporting.

Biopreserv Biobank 2012 Dec;10(6):501-10

1 BC BioLibrary, British Columbia, Canada .

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1089/bio.2012.0033DOI Listing
December 2012

Clonal evolution of high-grade serous ovarian carcinoma from primary to recurrent disease.

J Pathol 2013 Mar 29;229(4):515-24. Epub 2012 Nov 29.

BC Cancer Agency, Michael Smith Genome Sciences Centre, 675 West 10th Avenue, Vancouver, BC, V5Z 1 L3, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/path.4105DOI Listing
March 2013

The autophagy protein LC3A correlates with hypoxia and is a prognostic marker of patient survival in clear cell ovarian cancer.

J Pathol 2012 Dec;228(4):437-47

Deeley Research Centre, BC Cancer Agency, Victoria, BC, Canada; Department of Biochemistry and Microbiology, University of Victoria, BC, Canada; Canadian Institutes of Health Research Team in Investigating Autophagy Proteins as Molecular Targets for Cancer Treatments, Simon Fraser University, BC, Canada.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1002/path.4090
Publisher Site
http://dx.doi.org/10.1002/path.4090DOI Listing
December 2012

CD20+ tumor-infiltrating lymphocytes have an atypical CD27- memory phenotype and together with CD8+ T cells promote favorable prognosis in ovarian cancer.

Clin Cancer Res 2012 Jun 2;18(12):3281-92. Epub 2012 May 2.

Trev and Joyce Deeley Research Centre, British Columbia Cancer Agency, Department of Biochemistry and Microbiology, University of Victoria, Victoria, British Columbia, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-12-0234DOI Listing
June 2012

Oncostatin M suppresses oestrogen receptor-α expression and is associated with poor outcome in human breast cancer.

Endocr Relat Cancer 2012 Apr 10;19(2):181-95. Epub 2012 Apr 10.

Deeley Research Centre, BC Cancer Agency, Victoria, British Columbia, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1530/ERC-11-0326DOI Listing
April 2012

Tumor-infiltrating lymphocytes predict response to anthracycline-based chemotherapy in estrogen receptor-negative breast cancer.

Breast Cancer Res 2011 8;13(6):R126. Epub 2011 Dec 8.

Trev & Joyce Deeley Research Centre, British Columbia Cancer Agency, Victoria, British Columbia, V8R 6V5, Canada.

View Article

Download full-text PDF

Source
http://breast-cancer-research.biomedcentral.com/articles/10.
Publisher Site
http://dx.doi.org/10.1186/bcr3072DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3326568PMC
June 2012

A proposed schema for classifying human research biobanks.

Biopreserv Biobank 2011 Dec 3;9(4):327-33. Epub 2011 Oct 3.

1 Tumour Tissue Repository, Deeley Research Centre , BC Cancer Agency, Victoria, British Columbia, Canada .

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1089/bio.2011.0020DOI Listing
December 2011

The human face of biobank networks for translational research.

Biopreserv Biobank 2011 Sep;9(3):279-85

1 Department of Pathology, Hadassah-Hebrew University Medical Center , Jerusalem, Israel .

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1089/bio.2011.0018DOI Listing
September 2011

Intratumoral Immune Responses Can Distinguish New Primary and True Recurrence Types of Ipsilateral Breast Tumor Recurrences (IBTR).

Breast Cancer (Auckl) 2011 31;5:105-15. Epub 2011 May 31.

Deeley Research Centre, Vancouver Island Cancer Centre, British Columbia Cancer Agency, 2410 Lee Avenue, Victoria, BC, Canada, V8R 6V5.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4137/BCBCR.S7344DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3117626PMC
July 2011

Clinicopathologic factors of the recurrent tumor predict outcome in patients with ipsilateral breast tumor recurrence.

Cancer 2011 May 29;117(10):2035-43. Epub 2010 Nov 29.

Department of Oncology, McGill University Health Centre, Montreal, Quebec, Canada.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1002/cncr.25767
Publisher Site
http://dx.doi.org/10.1002/cncr.25767DOI Listing
May 2011

True recurrence versus new primary: an analysis of ipsilateral breast tumor recurrences after breast-conserving therapy.

Int J Radiat Oncol Biol Phys 2011 Oct 1;81(2):409-17. Epub 2011 Feb 1.

Department of Radiation Oncology, British Columbia Cancer Agency, Vancouver Island Centre, BC, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ijrobp.2010.05.063DOI Listing
October 2011

Clinical significance of estrogen receptor phosphorylation.

Endocr Relat Cancer 2011 Feb 19;18(1):R1-14. Epub 2011 Jan 19.

Department of Biochemistry and Medical Genetics, Faculty of Medicine Manitoba Institute of Cell Biology, University of Manitoba, 675 McDermot Avenue, Winnipeg, Manitoba, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1677/ERC-10-0070DOI Listing
February 2011

Ipsilateral breast tumor recurrence after breast-conserving therapy.

Expert Rev Anticancer Ther 2010 Aug;10(8):1229-38

British Columbia Cancer Agency, Vancouver Island Centre, University of British Columbia, 2410 Lee Avenue, Victoria, BC, V8R 6V5, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1586/era.10.87DOI Listing
August 2010

Biospecimen use in cancer research over two decades.

Biopreserv Biobank 2010 Jun;8(2):89-97

1 Tumour Tissue Repository, Trev and Joyce Deeley Research Centre, BC Cancer Agency , 2410 Lee Ave, Victoria, BC, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1089/bio.2010.0005DOI Listing
June 2010

A phosphorylation code for oestrogen receptor-alpha predicts clinical outcome to endocrine therapy in breast cancer.

Endocr Relat Cancer 2010 Sep 3;17(3):589-97. Epub 2010 Jun 3.

Department of Biochemistry and Medical Genetics, Faculty of Medicine Manitoba Institute of Cell Biology, University of Manitoba, 675 McDermot Avenue, Winnipeg, Manitoba, Canada R3E 0V9.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1677/ERC-10-0030DOI Listing
September 2010

Estrogen receptor alpha phosphorylated at tyrosine 537 is associated with poor clinical outcome in breast cancer patients treated with tamoxifen.

Horm Cancer 2010 Aug;1(4):215-21

Department of Biochemistry and Medical Genetics, Faculty of Medicine, University of Manitoba, Winnipeg, R3E 0V9, MB, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s12672-010-0049-zDOI Listing
August 2010

Structural and functional characterization of a triple mutant form of S100A7 defective for Jab1 binding.

Protein Sci 2009 Dec;18(12):2615-23

Department of Biochemistry and Microbiology, University of Victoria, Victoria, British Columbia, Canada.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1002/pro.274
Publisher Site
http://dx.doi.org/10.1002/pro.274DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2821279PMC
December 2009

Identification and characterization of binding sites on S100A7, a participant in cancer and inflammation pathways.

Biochemistry 2009 Nov;48(44):10591-600

Department of Chemistry, University of Victoria, P.O. Box 3065, Victoria, British Columbia V8W 3V6, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1021/bi901330gDOI Listing
November 2009

Density of tumour stroma is correlated to outcome after adoptive transfer of CD4+ and CD8+ T cells in a murine mammary carcinoma model.

Breast Cancer Res Treat 2010 Jun 30;121(3):753-63. Epub 2009 Sep 30.

Trev and Joyce Deeley Research Centre, British Columbia Cancer Agency, 2410 Lee Avenue, Victoria, BC V8R 6V5, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10549-009-0559-yDOI Listing
June 2010

The relevance of phosphorylated forms of estrogen receptor in human breast cancer in vivo.

J Steroid Biochem Mol Biol 2009 Mar 6;114(1-2):90-5. Epub 2009 Feb 6.

Manitoba Institute of Cell Biology, University of Manitoba, Winnipeg, Manitoba, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jsbmb.2009.01.017DOI Listing
March 2009

Claudins 1, 3, and 4 protein expression in ER negative breast cancer correlates with markers of the basal phenotype.

Virchows Arch 2009 Jun 23;454(6):647-56. Epub 2009 Apr 23.

Department of Pathology, University of Manitoba, 770 Bannatyne Avenue, Winnipeg, Manitoba, Canada R3E0W3.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00428-009-0770-6DOI Listing
June 2009

Mammary tumors with diverse immunological phenotypes show differing sensitivity to adoptively transferred CD8+ T cells lacking the Cbl-b gene.

Cancer Immunol Immunother 2009 Nov 7;58(11):1865-75. Epub 2009 Apr 7.

Trev and Joyce Deeley Research Centre, British Columbia Cancer Agency, 2410 Lee Avenue, Victoria, BC V8R 6V5, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00262-009-0698-3DOI Listing
November 2009

Highly homologous hS100A15 and hS100A7 proteins are distinctly expressed in normal breast tissue and breast cancer.

Cancer Lett 2009 May 10;277(1):101-7. Epub 2009 Jan 10.

Laboratory of Cancer Biology and Genetics, Center for Cancer Research, National Cancer Institute, National Institutes of Health, 37 Convent Drive, Bethesda, MD 20892-4255, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.canlet.2008.11.032DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2680177PMC
May 2009

Immunohistochemical validation of multiple phospho-specific epitopes for estrogen receptor alpha (ERalpha) in tissue microarrays of ERalpha positive human breast carcinomas.

Breast Cancer Res Treat 2009 Dec 23;118(3):443-53. Epub 2008 Dec 23.

Department of Biochemistry and Medical Genetics, Faculty of Medicine, University of Manitoba, 675 McDermot Avenue, Winnipeg, MB, R3E 0V9, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10549-008-0267-zDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3448371PMC
December 2009

Influence of evolution in tumor biobanking on the interpretation of translational research.

Cancer Epidemiol Biomarkers Prev 2008 Dec;17(12):3344-50

Tumour Tissue Repository and Deeley Research Center, BC Cancer Agency, Victoria, British Columbia, Canada.

View Article

Download full-text PDF

Source
http://cebp.aacrjournals.org/cgi/doi/10.1158/1055-9965.EPI-0
Publisher Site
http://dx.doi.org/10.1158/1055-9965.EPI-08-0622DOI Listing
December 2008

Jab1 is a target of EGFR signaling in ERalpha-negative breast cancer.

Breast Cancer Res 2008 6;10(3):R51. Epub 2008 Jun 6.

Deeley Research Center, BC Cancer Agency, Vancouver Island Center, Victoria, BC, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/bcr2105DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2481501PMC
November 2008

Estrogen receptor alpha negative breast cancer patients: estrogen receptor beta as a therapeutic target.

J Steroid Biochem Mol Biol 2008 Mar 8;109(1-2):1-10. Epub 2007 Dec 8.

Manitoba Institute of Cell Biology, Department of Biochemistry & Medical Genetics, University of Manitoba, Winnipeg, Manitoba, Canada R3E OV9.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jsbmb.2007.12.010DOI Listing
March 2008

Spontaneous mammary tumors differ widely in their inherent sensitivity to adoptively transferred T cells.

Cancer Res 2007 Jul;67(13):6442-50

Trev & Joyce Deeley Research Centre, British Columbia Cancer Agency, Victoria, British Columbia, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/0008-5472.CAN-07-0622DOI Listing
July 2007

S100A7 (psoriasin) influences immune response genes in human breast cancer.

Exp Cell Res 2007 Aug 30;313(14):3016-25. Epub 2007 Mar 30.

Department of Pathology, University of Manitoba, Winnipeg, Manitoba, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.yexcr.2007.03.020DOI Listing
August 2007

Estrogen receptor-alpha phosphorylated at Ser118 is present at the promoters of estrogen-regulated genes and is not altered due to HER-2 overexpression.

Cancer Res 2006 Oct;66(20):10162-70

Department of Biochemistry and Medical Genetics and Department of Pathology, Manitoba Institute of Cell Biology, University of Manitoba, Winnipeg, Manitoba, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/0008-5472.CAN-05-4111DOI Listing
October 2006

Estrogen receptor-beta regulates psoriasin (S100A7) in human breast cancer.

Breast Cancer Res Treat 2007 Jul 29;104(1):75-85. Epub 2006 Sep 29.

Department of Biochemistry & Medical Genetics, University of Manitoba, Winnipeg, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10549-006-9390-xDOI Listing
July 2007

Tumor cell expression of HLA-DM associates with a Th1 profile and predicts improved survival in breast carcinoma patients.

Int Immunol 2006 Nov 20;18(11):1591-602. Epub 2006 Sep 20.

Division of Basic Medical Sciences, Faculty of Medicine, Memorial University of Newfoundland, St John's, Newfoundland, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/intimm/dxl092DOI Listing
November 2006

Is oestrogen receptor-beta a predictor of endocrine therapy responsiveness in human breast cancer?

Endocr Relat Cancer 2006 Jun;13(2):327-34

Manitoba Institute of Cell Biology, Department of Biochemistry and Medical Genetics, University of Manitoba, and Cancer Care Manitoba Winnipeg, Canada R3E 0V9.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1677/erc.1.01141DOI Listing
June 2006

Assessment of multiple different estrogen receptor-beta antibodies for their ability to immunoprecipitate under chromatin immunoprecipitation conditions.

Breast Cancer Res Treat 2006 Nov 17;100(1):23-31. Epub 2006 May 17.

Manitoba Institute of Cell Biology, Department of Biochemistry & Medical Genetics, University of Manitoba, 675 McDermot Avenue, R3E 0V9 Winnipeg, Manitoba, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10549-006-9229-5DOI Listing
November 2006

Breast tissue banking: collection, handling, storage, and release of tissue for breast cancer research.

Methods Mol Med 2006 ;120:3-24

Department of Pathology, University of Manitoba, Winnipeg, Canada.

View Article

Download full-text PDF

Source
March 2006

Differential expression of claudin 1, 3, and 4 during normal mammary gland development in the mouse.

DNA Cell Biol 2006 Feb;25(2):79-86

Department of Pathology and Physiology, University of Manitoba, Winnipeg, Manitoba, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1089/dna.2006.25.79DOI Listing
February 2006

Real-time PCR complements immunohistochemistry in the determination of HER-2/neu status in breast cancer.

BMC Clin Pathol 2006 Jan 18;6. Epub 2006 Jan 18.

Department of Pathology, University of Manitoba, 770 Bannatyne Ave,, Winnipeg, Manitoba R3E 0W3, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/1472-6890-6-2DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1382241PMC
January 2006

Intermittent hypoxia induces proteasome-dependent down-regulation of estrogen receptor alpha in human breast carcinoma.

Clin Cancer Res 2004 Dec;10(24):8720-7

Manitoba Institute of Cell Biology and Department of Pathology, University of Manitoba, Faculty of Medicine, Winnipeg, Manitoba, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-04-1235DOI Listing
December 2004

HLA-DRB alleles are differentially expressed by tumor cells in breast carcinoma.

Int J Cancer 2004 Nov;112(3):399-406

Division of Basic Medical Sciences, Faculty of Medicine, Memorial University of Newfoundland, St. John's, Newfoundland, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ijc.20441DOI Listing
November 2004

S100 proteins and their influence on pro-survival pathways in cancer.

Biochem Cell Biol 2004 Aug;82(4):508-15

Manitoba Institute of Cell Biology, Winnipeg, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1139/o04-052DOI Listing
August 2004

The hypoxia-regulated transcription factor DEC1 (Stra13, SHARP-2) and its expression in human tissues and tumours.

J Pathol 2004 Jul;203(3):808-13

Cancer Research UK Molecular Oncology Laboratory, Weatherall Institute of Molecular Medicine, John Radcliffe Hospital, Oxford OX3 9DS, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/path.1585DOI Listing
July 2004

S100A7 (psoriasin) expression is associated with aggressive features and alteration of Jab1 in ductal carcinoma in situ of the breast.

Breast Cancer Res 2004 26;6(4):R308-15. Epub 2004 Apr 26.

Manitoba Institute of Cell Biology and Department of Pathology, University of Manitoba, Faculty of Medicine, Winnipeg, Manitoba, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/bcr791DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC468627PMC
November 2004

S100A7 and the progression of breast cancer.

Breast Cancer Res 2004 4;6(4):153-9. Epub 2004 Jun 4.

Manitoba Institute of Cell Biology, University of Manitoba, Winnipeg, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/bcr816DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC468668PMC
November 2004

Necrosis and hypoxia in invasive breast carcinoma.

Breast Cancer Res Treat 2003 Sep;81(1):61-9

Faculty of Medicine, Department of Pathology, University of Manitoba, Winnipeg, MB, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1023/A:1025476722493DOI Listing
September 2003

Relationship between mammaglobin expression and estrogen receptor status in breast tumors.

Endocrine 2003 Aug;21(3):245-50

Departments of Biochemistry and Medical Genetics, University of Manitoba, Faculty of Medicine, Winnipeg, Manitoba, Canada, R3EOW3.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1385/ENDO:21:3:245DOI Listing
August 2003

Mammographic density is related to stroma and stromal proteoglycan expression.

Breast Cancer Res 2003 23;5(5):R129-35. Epub 2003 Jul 23.

Department of Pathology and Molecular Medicine, McMaster University, Hamilton, Ontario, Canada.

View Article

Download full-text PDF

Source
http://breast-cancer-research.biomedcentral.com/articles/10.
Publisher Site
http://dx.doi.org/10.1186/bcr622DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC314426PMC
October 2003

Expression of the mouse homologue for the human GCDFP-15/PIP gene during pre- and early post-natal development.

Mol Cell Endocrinol 2003 Jul;205(1-2):33-41

Department of Pathology, Faculty of Medicine, University of Manitoba, 770 Bannatyne Avenue, Man., R3E 0W3 Winnipeg, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/s0303-7207(03)00210-7DOI Listing
July 2003

Psoriasin (S100A7) expression is associated with poor outcome in estrogen receptor-negative invasive breast cancer.

Clin Cancer Res 2003 Jul;9(7):2627-31

Departments of Pathology, University of Manitoba, Faculty of Medicine, Winnipeg, Manitoba, R3E OW3 Canada.

View Article

Download full-text PDF

Source
July 2003